Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hokuyaku Takeyama Holdings's quarterly market cap
increased
from Mar. 2025 (円18,642 Mil) to Sep. 2025 (円19,062 Mil) but then
declined
from Sep. 2025 (円19,062 Mil) to Mar. 2026 (円18,932 Mil).
Hokuyaku Takeyama Holdings's annual market cap
declined
from Mar. 2024 (円18,717 Mil) to Mar. 2025 (円18,642 Mil) but then
increased
from Mar. 2025 (円18,642 Mil) to Mar. 2026 (円18,932 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hokuyaku Takeyama Holdings's Enterprise Value for Today is 円1,685 Mil.
Hokuyaku Takeyama Holdings (SSE:3055) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Hokuyaku Takeyama Holdings Market Cap Related Terms
Hokuyaku Takeyama Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Hokuyaku Takeyama Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hokuyaku Takeyama Holdings Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Hokuyaku Takeyama Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Hokuyaku Takeyama Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hokuyaku Takeyama Holdings (SSE:3055) has a Market Cap of 円18,747 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hokuyaku Takeyama Holdings and its competitors. According to the industry distribution chart, Hokuyaku Takeyama Holdings ranks #67 out of 120 companies in the Medical Distribution industry, placing it in the top 55.8%.
Is Hokuyaku Takeyama Holdings' Market Cap too high?
Hokuyaku Takeyama Holdings' current Market Cap is 円18,747 Mil. Based on the distribution chart, Hokuyaku Takeyama Holdings ranks #67 out of 120 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Hokuyaku Takeyama Holdings has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hokuyaku Takeyama Holdings' Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Hokuyaku Takeyama Holdings ranks #67 out of 120 companies for Market Cap. This places Hokuyaku Takeyama Holdings in the lower half of its industry. The industry median Market Cap is 137.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 137.54, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hokuyaku Takeyama Holdings and its competitors. For the Medical Distribution industry, the median Market Cap is 137.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hokuyaku Takeyama Holdings's current Market Cap is 円18,747 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hokuyaku Takeyama Holdings stock overvalued right now?
Based on GuruFocus' analysis, Hokuyaku Takeyama Holdings (SSE:3055) is currently considered Fairly Valued. The stock's GF Value™ is 円956.39, compared to a current price of 円912.00 — trading 4.6% below its estimated fair value. The current Market Cap is 円18,747 Mil. Hokuyaku Takeyama Holdings' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Hokuyaku Takeyama Holdings (SSE:3055), the current Market Cap is 円18,747 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hokuyaku Takeyama Holdings (SSE:3055) Overvalued in 2026?
Based on GuruFocus' analysis, Hokuyaku Takeyama Holdings stock appears to be undervalued.
The current stock price of 円912.00 is trading 4.6% below its estimated GF Value™ of 円956.39.
GuruFocus considers Hokuyaku Takeyama Holdings to be Fairly Valued.
Key valuation signals for SSE:3055:
Market Cap: 円18,747 Mil
GF Value™: 円956.39 vs. price of 円912.00 (4.6% below fair value)
No single metric tells the full story. See the SSE:3055 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hokuyaku Takeyama Holdings Inc is a medical device wholesaler. The company also distributes ethical drugs and general-purpose medicines. It offers repair services for medical instruments and manages real estate for physics and chemistry instruments.
56GF Score
Get the complete analysis for SSE:3055
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSE:3055 has been successfully added to your 
